Clinical Trial Update: Guanfacine to Reduce Relapse Risk in Women With Alcohol Use Disorder (AUD) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports Phase 1 and Phase 2 results evaluating guanfacine for reducing relapse risk in women with alcohol use disorder; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Guanfacine (guanfacine)

Snippet

Sponsor: Stony Brook University | Conditions: Alcohol Abstinence | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-06-05